MYD88 and lymphoma: Previous studies have reported transcriptomic profiles of primary lymphoma cells bearing MyD88 mutations [26,30,31,67]; however, to the best of our knowledge, this is the first study solely addressing the transcriptomic response of MyD88L265P in a well-characterized and tightly controlled cellular model system.